Nasus Pharma Ltd. (NYSEAMERICAN:NSRX – Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totaling 87,272 shares, a decline of 39.6% from the August 15th total of 144,506 shares. Based on an average daily volume of 14,783 shares, the days-to-cover ratio is currently 5.9 days. Approximately 0.7% of the shares of the company are short sold.
Nasus Pharma Stock Performance
NSRX stock traded down $0.06 during trading on Wednesday, hitting $3.53. The company had a trading volume of 4,948 shares, compared to its average volume of 86,082. The business has a 50 day moving average of $3.45 and a 200 day moving average of $3.25. Nasus Pharma has a fifty-two week low of $1.98 and a fifty-two week high of $9.50.
Nasus Pharma (NYSEAMERICAN:NSRX – Get Free Report) last released its earnings results on Monday, August 17th. The company reported ($0.27) EPS for the quarter. Sell-side analysts predict that Nasus Pharma will post -0.93 earnings per share for the current fiscal year.
About Nasus Pharma
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.
Recommended Stories
- Five stocks we like better than Nasus Pharma
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
